Abstract
Objective
To investigate antimicrobial effects of ethanolic extract of Zingiber zerumbet (Z. zerumbet) (L.) Smith and its chloroform and petroleum ether soluble fractions against pathogenic bacteria and fungi.
Methods
The fresh rhizomes of Zingiber zerumbet were extracted in cold with ethanol (4.0 L) after concentration. The crude ethanol extract was fractionated by petroleum ether and chloroform to form a suspension of ethanol extract (15.0 g), petroleum ether fraction (6.6 g) and chloroform soluble fraction (5.0 g). The crude ethanol extract and its petroleum ether and chloroform fractions were evaluated for antibacterial and antifungal activity against thirteen pathogenic bacteria and three fungi by the disc diffusion method. Commercially available kanamycin (30 µg/disc) was used as standard disc and blank discs impregnated with the respective solvents were used as negative control.
Results
At a concentration of 400 µg/disc, all the samples showed mild to moderate antibacterial and antifungal activity and produced the zone of inhibition ranging from 6 mm to 10 mm. Among the tested samples, the crude ethanol extract showed the highest activity against Vibrio parahemolyticus (V. parahemolyticus). The minimum inhibitory concentration (MIC) of the crude ethanol extract and its fractions were within the value of 128-256 µg/mL against two Gram positive and four Gram negative bacteria and all the samples showed the lowest MIC value against V. parahemolyticus (128 µg/mL).
Conclusions
It can be concluded that, potent antibacterial and antifungal phytochemicals are present in ethanol extract of Z. zerumbet (L).
Keywords: Zingiber zerumbet (L.) Smith, Antibacterial, Antifungal, Minimum inhibitory concentration (MIC), Antimicrobial activity, Rhizome, Antifungal activity, Phytochemicals, Disc diffusion method, Soluble fraction, Pathogenic bacteria
1. Introduction
Many plants are used as folk medicines to infectious diseases such as urinary tract infections, diarrhea, cutaneous abscesses, bronchitis and parasitic diseases[1]–[4]. Due to the indiscriminate use of antibacterial drugs, the microorganisms have developed resistance to many commercial antibiotics. Therefore, investigation of the chemical compounds within medicinal plants has become desirable[5]. Even though certain plants have been demonstrated for their effects on pathogenic bacteria[6], a number of them have not yet been investigated for their antimicrobial activities. Hence, it is essential to establish the scientific basis for their therapeutic actions as these may serve as the source for the development of effective drugs.
The present study was undertaken to investigate the potential of medicinal plant, Zingiber zerumbet (Z. zerumbet) (L.) Smith as antimicrobial agent against some pathogenic Gram positive and Gram negative bacteria and some pathogenic fungi. Z. zerumbet (L.), known by various names, for example, “Bon adha” (Bangladesh), “Ghatian” and “Yaiimu” (India), “Lempoyang” (Malaysia and Indonesia), “Awapuhi” (Hawaii), “Zurunbah” (Arab), “Hong qiu jiang” (China), and “Haeo dam” or “Hiao dam” (Northern Thailand)[2],[3],[7],[8], is a member of the family Zingiberaceae and widely cultivated throughout the tropics including Southeast Asia, Korea, India and Bangladesh for its medicinal properties[9]–[11]. Its rhizomes are used in the traditional medicine as a cure for swelling, loss of appetite, lumbago, diabetes, inflammation, chest pain, rheumatic pains, bronchitis, dyspepsia and sore throat[2],[3],[7],[12]. The juice of the boiled rhizomes has also been used in indigenous medicine for worm infestation in children[13],[14]. From the pharmacological point of view, Z. zerumbet has been reported to inhibit colon and lung carcinogenesis in mice[15] and CXCL12-induced invasion of breast and pancreatic tumor cells[16], apoptosis in liver cancer[17], suppress phorbol ester-induced expression of multiple scavenger receptor genes in THP-1 human monocytic cells and Epstein-Barr Virus activation[18],[19]. Bioactive compound(s) isolated and identified from various types of extracts of Z. zerumbet, only zerumbone has been studied extensively. Zerumbone has been demonstrated to possess in vivo antinociceptive[20] and anti-inflammatory[21]–[23] activities. While in the in vitro studies, zerumbone has been reported to exhibit antiproliferative[20] and antiplatelet aggregation[24] activities.
In our laboratory we have also found the anti-staphylococcal activity of zederone, isolated from the ethanolic extract of Z. zerumbet (L.) Smith against a series of multi-drug resistant (MDR) and methicillin resistant Staphylococcus aureus strains: SA1199B, ATCC25923, XU212, RN4220 and EMRSA15[25]. These lead us to evaluate the antibacterial, MIC and antifungal activities of the ethanol extract and its different fractions of the rhizomes of Z. zerumbet (L.) Smith against thirteen pathogenic bacteria and three fungi.
2. Materials and methods
2.1. Plant materials
Fresh rhizomes of Z. zerumbet were collected from the hilly areas of Chittagong, Bangladesh and identified by a taxonomist, Dr. Mohammed Yusuf, BCSIR Laboratory, Chittagong, Bangladesh where a voucher specimen (No. 1061) of this collection was deposited.
2.2. Extraction and fractionation
Fresh rhizomes of Z. zerumbet were sun dried for 7 days and finally autoclaved in an electric oven below 60 °C for 23 hours. The dried powdered plant materials (800 g) of Z. zerumbet were extracted in room temperature with ethanol (4.0 L) in an aspirator bottle for a week and then filtered. The filtrate was then concentrated by using a rotary evaporator at 45 °C under reduced pressure. The crude ethanol extract (15.0 g) was fractionated by solvent-solvent partitioning with petroleum ether (40-60 °C) and chloroform, yielding petroleum ether fraction (6.6 g) and chloroform soluble fraction (5.0 g).
2.3. Antimicrobial activity
The crude ethanol extract and their fractions were tested for their antibacterial activity against five Gram positive and eight Gram negative bacteria and three pathogenic fungi by disc diffusion method[26]. Thirteen pathogenic bacteria [Bacillus cereus (B. cereus) QL 29, Bacillus megaterium (B. megaterium) QL 38, Bacillus subtilis (B. subtilis) QL 40, Staphylococcus aureus (S. aureus) ATCC25923, Sarcina lutea (S. lutea) QL 166, Escherichia coli (E. coli) ATCC 25922, Pseudomonas aeruginosa (P. aeruginosa) ATCC 27853, Salmonella paratyphi (S. paratyphi) A AM16590, Salmonella typhi (S. typhi) AM 16406, Shigella boydii (S. boydii) ATCC13147, Shigella dysenteriae (S. dysenteriae) ATCC 26131, Vibrio mimicus (V. mimicus) N 1967, Vibrio parahemolyticus (V. parahemolyticus) AM 16362] and three fungi [Candida albicans (C. albicans), Aspergillus niger (A. niger), Sacharomyces cerevaceae (S. cerevaceae)] were collected as pure culture from the Institute of Nutrition and Food Science (INFS), University of Dhaka, Bangladesh. The sample solution of the plant materials (extract and fractions) were prepared by dissolving definite amounts of materials in appropriate solvent to attain the desired concentration and then applied to sterile disc (5 mm diameter, filter paper) followed by drying off the solvent in an aseptic hood. To compare the activity with standard antibiotics, kanamycin discs (30 µg/disc) and blank discs impregnated with the respective solvents were used as positive control and negative control, respectively.
2.4. Minimum inhibitory concentration (MIC)
MIC of crude ethanol extract and their fractions were determined by serial dilution technique[27] against B. cereus QL 29, S. lutea QL 166, V. parahemolyticus AM 16362, E. coli ATCC 25922, S. typhi AM 16406 and P. aeruginosa ATCC 27853.
3. Results
The results of antibacterial and antifungal activities of crude ethanol extract and its petroleum ether and chloroform fractions of the rhizome of Z. zerumbet (L) were presented in Table 1. The zones of inhibition produced by the crude ethanol extract, petroleum ether and chloroform fraction were ranged from 9-10 mm, 8-9 mm and 6-8 mm, respectively at a concentration of 400 µg/disc. The petroleum ether and chloroform fractions showed mild to moderate activity against all the bacteria and fungi. But the crude ethanol extract showed the highest antibacterial activity (10 mm) against V. parahemolyticus and also showed good antifungal activity (9 mm) against all pathogenic fungi. The MIC of the crude ethanol extract and petroleum ether and chloroform fractions of the rhizome of Z. zerumbet (L) were within the values of 128-256 µg/mL against 2 Gram positive (B. cereus and S. lutea) and 4 Gram negative (V. parahemolyticus, E. coli, S. typhi and P. aeruginosa) pathogenic bacteria and all the samples showed the lowest MIC value (128 µg/mL) against V. parahemolyticus (Table 2).
Table 1. In vitro antimicrobial activity of crude ethanol extract and its different fractions.
| Test Bacteria | Zone of inhibition (Diameter in mm) |
||||
| Crude ethanol extract (400 µg/disc) | Petroleum ether fraction (400 µg/disc) | Chloroform fraction (400 µg/disc) | Kanamycin (30 µg/disc) | ||
| Gram positive bacteria | |||||
| B. cereus | 9 | 8 | 7 | 30 | |
| B. megaterium | 9 | 8 | 7 | 31 | |
| B. subtilis | 9 | 8 | 7 | 30 | |
| S. aureus | 8 | 9 | 6 | 30 | |
| S. lutea | 9 | 9 | 7 | 30 | |
| Gram negative bacteria | |||||
| E. coli | 9 | 8 | 6 | 30 | |
| S. paratyphi | 9 | 8 | 7 | 30 | |
| S. typhi | 9 | 9 | 7 | 30 | |
| V. parahemolyticus | 10 | 9 | 7 | 30 | |
| V. mimicus | 9 | 9 | 8 | 30 | |
| S. dysenteriae | 9 | 8 | 6 | 30 | |
| S. boydii | 9 | 9 | 6 | 31 | |
| P. aeruginosa | 9 | 8 | 7 | 30 | |
| Fungi | |||||
| C. albicans | 9 | 9 | 6 | 31 | |
| A. niger | 9 | 8 | 7 | 31 | |
| S. cerevaceae | 9 | 8 | 7 | 31 | |
Table 2. MIC values of crude ethanol extract and its different fractions (µg/mL).
| Test bacteria |
Z. zerumbet Linn. |
||
| Crude ethanol extract | Petroleum ether fraction | Chloroform fraction | |
| B. sereus | 256 | 128 | 256 |
| S. lutea | 128 | 256 | 256 |
| V. parahemolyticus | 128 | 128 | 128 |
| E. coli | 128 | 128 | 256 |
| S. typhi | 256 | 128 | 128 |
| P. aeruginosa | 128 | 256 | 256 |
4. Discussion
Presently there is an increasing interest worldwide in herbal medicines accompanied by increased laboratory investigation into the pharmacological properties of the bioactive ingredients and their ability to treat various diseases[28]. Zingiberaceae plants have been received much attention, since they can produce many complex compounds that are useful in food as herbs and spices, flavoring and seasoning, and in the cosmetics and medicinal industries as antioxidant and antimicrobial agents[29].
The antibacterial activity and inhibition activity of Z. zerumbet extracts could be attributed to the chemical compounds. Phytochemical investigations demonstrated the presence of zerumbone, zerumbone epoxide, diferuloylmethane, feruloyl-p-coumaroyl-methane, di-p-coumaroyl-methane sesquiterpenoids, flavonoids, aromatic compounds (e.g., hydroxybenzaldehyde), vanillin. Recent study has revealed the presence of a sesquiterpene, zederone, phenolic, saponins, and terpenoids in ethanol extract of Z. zerumbet[25],[30].
The results for the antibacterial screening have shown that the entire extracts have antibacterial activity.
The results of this study reflect that potent antibacterial and antifungal phytochemicals are present in ethanol extract of Z. zerumbet (L). These findings are supported by the reported results of species of Zingiberaceae plants such as Zingiber cassumunar and Alpinia galanga, Boesenbergia rotunda, Piper betel, Barleria lupulina, Curcuma mangga and Zingiber nimmonii which exhibited antibacterial activity[31]–[34].
Several medicinal plants exihibiting antimycobacterial activity, including Z. zerumbet, are used as self-medication by AIDS patients in Thailand[35]. So, the crude ethanol extract of Z. zerumbet was biologically active and can be considered as a good candidate for further investigation.
Acknowledgments
The authors wish to thank Institute of Nutrition and Food Science (INFS), University of Dhaka, Bangladesh for providing pathogenic microorganisms for the study and Bangladesh ministry of science, information and communication technology for financial support.
Footnotes
Foundation Project: Supported by Innovation Technology, Research and Development Project, Ministry of Science, Information and Communication Technology. Republic of Bangladesh Government (No. 12).
Conflict of interest statement: We declare that we have no conflict of interest.
References
- 1.Yasunaka K, Abe F, Nagayama A, Okabe H, Perez LL, Villafranco EL, et al. et al. Antibacterial activity of crude extracts from Mexican medicinal plants and purified coumarins and xanthones. J Ethnopharmacol. 2005;97:293–299. doi: 10.1016/j.jep.2004.11.014. [DOI] [PubMed] [Google Scholar]
- 2.Bhuiyan MNI, Chowdhury JU, Begum J. Chemical investigation of the leaf and rhizome essential oils of Zingiber zerumbet (L.) Smith from Bangladesh. Bangladesh J Pharmacol. 2009;4(1):9–12. [Google Scholar]
- 3.Zakaria ZA, Mohamad AS, Chear CT, Wong YY, Israf DA, Sulaiman MR. Antiinflammatory and antinociceptive activities of Zingiber zerumbet methanol extract in experimental model systems. Med Princ Pract. 2010;19(4):287–294. doi: 10.1159/000312715. [DOI] [PubMed] [Google Scholar]
- 4.Yob NJ, Jofrry SM, Affandi MMR, Teh LK, Salleh MZ, Zakaria Z A. Zingiber zerumbet (L.) Smith: a review of its ethnomedicinal, chemical, and pharmacological uses. Evid Based Complement Alternat Med. 2011 doi: 10.1155/2011/543216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ahmad I, Mehmood Z, Mohammad F. Screening of some Indian medicinal plants for their antimicrobial properties. J Ethonopharmacol. 1998;62:183–193. doi: 10.1016/s0378-8741(98)00055-5. [DOI] [PubMed] [Google Scholar]
- 6.Voravuthikunchai SP, Popaya W, Supavita T. Antibacterial activity of crude extracts of medicinal plants used in Thailand against pathogenic bacteria. J Ethnopharmacol. 2004;33:60–65. [Google Scholar]
- 7.Zakaria ZA, Mohamad AS, Ahmad MS, Mokhtar AF, Israf DA, Lajis NH, et al. et al. Preliminary analysis of the anti-inflammatory activity of essential oils of Zingiber zerumbet. Biol Res Nurs. 2010 doi: 10.1177/1099800410386590. [DOI] [PubMed] [Google Scholar]
- 8.Tushar, Basak S, Sarma GC, Rangan L. Ethnomedical uses of Zingiberaceous plants of Northeast India. J Ethnopharmacol. 2010;132:286–296. doi: 10.1016/j.jep.2010.08.032. [DOI] [PubMed] [Google Scholar]
- 9.Fansworth NR, Bunyapraphatsara N. Thai Medicinal Plants. 1992. pp. 261–263. Prachachon, Bangkok, Thailand.
- 10.Kirtikar RK, Basu BD. Indian medicinal plant. Allahabad: Lalit Mohan Basu Publications; 1984. pp. 2415–2419. [Google Scholar]
- 11.Saadiah MS, Halijah I. Proceedings of the National Convention on Herbal medicine. Kuala Lumpur: Forest Research Institute Malaysia; 1995. pp. 205–207. [Google Scholar]
- 12.Sulaiman MR, Tengku Mohamad TAS, Shaik Mossadeq WM, Moin S, Yusof M, Mokhtar AF, et al. et al. Antinociceptive activity of the essential oil of Zingiber zerumbet. Planta Med. 2010;76(2):107–112. doi: 10.1055/s-0029-1185950. [DOI] [PubMed] [Google Scholar]
- 13.Ruslay S, Abas F, Shaari K, Zainal Z, Maulidiani, Sirat H, Israf DA, et al. Characterization of the components present in the active fractions of health gingers (Curcuma xanthorrhiza and Zingiber zerumbet) by HPLC-DAD-ESIMS. Food Chem. 2007;104(3):1183–1191. [Google Scholar]
- 14.Burkill H. Ministry of Agric and Coop, Kuala Lumpur; 1966. Dictionary of the economic products of the Malay Peninsula. [Google Scholar]
- 15.Kim M, Miyamoto S, Yasui Y, Oyama T, Murakami A, Tanaka T. Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice. Int J Cancer. 2009;124:264–271. doi: 10.1002/ijc.23923. [DOI] [PubMed] [Google Scholar]
- 16.Sung B, Jhurani S, Ahn KS, Mastuo Y, Yi T, Guha S, et al. et al. Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells. Cancer Res. 2008;68:8938–8944. doi: 10.1158/0008-5472.CAN-08-2155. [DOI] [PubMed] [Google Scholar]
- 17.Sakinah SAS, Handayani ST, Hawariah LPA. Zerumbone induced apoptosis in liver cancer, HepG2 cells via modulation of Bax/Bcl-2 ratio. Cancer Cell Int. 2007;7:4. doi: 10.1186/1475-2867-7-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Vimala S, Norhanom AW, Yadav M. Anti-tumour promoter activity in Malaysian ginger rhizobia used in traditional medicine. Br J Cancer. 1999;80:110–116. doi: 10.1038/sj.bjc.6690329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Murakami A, Takahashi M, Jiwajinda S, Koshimizu K, Ohigashi H. Identification of zerumbone in Zingiber zerumbet Smith as a potent inhibitor of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation. Biosci Biotechnol Biochem. 1999;63:1811–1812. doi: 10.1271/bbb.63.1811. [DOI] [PubMed] [Google Scholar]
- 20.Sulaiman MR, Perimal EK, Zakaria ZA, Mokhtar F, Akhtar MN, Lajis NH, et al. et al. Preliminary analysis of the antinociceptive activity of zerumbone. Fitoterapia. 2009;80(4):230–232. doi: 10.1016/j.fitote.2009.02.002. [DOI] [PubMed] [Google Scholar]
- 21.Sulaiman MR, Perimal EK, Akhtar MN, Mohamad AS, Khalid MH, Tasrip NA, et al. et al. Anti-inflammatory effect of zerumbone on acute and chronic inflammation models in mice. Fitoterapia. 2010;81:855–858. doi: 10.1016/j.fitote.2010.05.009. [DOI] [PubMed] [Google Scholar]
- 22.Chaung HC, Ho CT, Huang TC. Anti-hypersensitive and anti-inflammatory activities of water extract of Zingiber zerumbet (L.) Smith. Food Agric Immunol. 2008;19(2):117–129. [Google Scholar]
- 23.Chien TY, Chen LG, Lee CJ, Lee FY, Wang CC. Anti-inflammatory constituents of Zingiber zerumbet. Food Chem. 2008;110(3):584–589. [Google Scholar]
- 24.Jantan I, Raweh SM, Sirat HM, Jamil S, Mohd Yasin YH, Jalil J, et al. et al. Inhibitory effect of compounds from Zingiberaceae species on human platelet aggregation. Phytomedicine. 2008;15(4):306–309. doi: 10.1016/j.phymed.2007.08.002. [DOI] [PubMed] [Google Scholar]
- 25.Kader MG, Habib MR, Nikkon F, Yeasmin T, Rashid MA, Rahman MM, et al. et al. Zederone from the rhizomes of Zingiber zerumbet and its anti-staphylococcal activity. Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas. 2010;9(1):63–68. [Google Scholar]
- 26.Vander BDA, Vlietnck AJ. Screening methods for antibacterial and antiviral agents from higher plants. In: Dey PM, Harborne JB, Hostiettman K, editors. Methods in plant biochemistry. London: Academic Press; 1991. pp. 47–69. [Google Scholar]
- 27.Reiner R. Antibiotics and introduction. Switzerland: Roche Scientific Services; 1982. pp. 21–27. [Google Scholar]
- 28.Lobo R, Prabhu KS, Shirwaikar A, Shirwaikar A. Curcuma zedoaria Rosc. (white turmeric): a review of its chemical, pharmacological and ethnomedicinal properties. J Pharm Pharmacol. 2009;61:13–21. doi: 10.1211/jpp/61.01.0003. [DOI] [PubMed] [Google Scholar]
- 29.Chen IN, Chang CC, Ng CC, Wang CY, Shyu YT, Chang TL. Antioxidant and antimicrobial activity of Zingiberaceae plants in Taiwan. Plant Foods Hum Nutr. 2008;63:15–20. doi: 10.1007/s11130-007-0063-7. [DOI] [PubMed] [Google Scholar]
- 30.Hashemi SR, Zulkifli I, Bejo MH, Farida A, Somchit MN. Acute toxicity study and phytochemical screening of selected herbal aqueous extract in broiler chickens. Int J Pharmacol. 2008;4(5):352–360. [Google Scholar]
- 31.Khalequzzaman M, Gazi MMR, Das BC. Antimicrobial activities of the rhizome and leaf extracts of Zingiber cassumunar Roxb. Bangladesh J Genet Biotechnol. 2002;3:35–40. [Google Scholar]
- 32.Voravuthikuchai SP, Limsuwan S, Supapol O, Subhadhiraskul S. Antibacterial activity of extracts from family Zingiberaceae against foodborne pathogens. J Food Saf. 2006;26(4):325–334. [Google Scholar]
- 33.Philip K, Malek SNA, Sani W, Shin SK, Kumar S, Lai HK, et al. et al. Antimicrobial activity of some medicinal plants from Malaysia. Am J Appl Sci. 2009;6(8):1613–1617. [Google Scholar]
- 34.Sabulal B, Dan M, John JA, Kurup R, Pradeep NS, Valsamma RK, et al. et al. Caryophyllene-rich rhizome oil of Zingiber nimmonii from South India: chemical characterization and antimicrobial activity. Phytochemistry. 2006;67(22):2469–2473. doi: 10.1016/j.phytochem.2006.08.003. [DOI] [PubMed] [Google Scholar]
- 35.Phongpaichit S, Vuddhakul V, Subhadhirasakul S, Wattanapiromsakul C. Evaluation of the antimycobacterial activity of extracts from plants used as self-medication by AIDS patients in Thailand. Pharm Biol. 2006;44(1):71–75. [Google Scholar]
